As previously announced, the Board of FRISQ Holding AB ("FRISQ") has decided to initiate a formal, exclusive process with the objective to divest its operative business to Cambio Healthcare Systems AB ("Cambio"). The discussions held between the parties have been positive and both parties intend to complete the transaction as soon as possible. Certain technical details are currently being investigated and Cambio has therefore asked FRISQ to extend the exclusive period by up to one more month, i.e. until the end of October. The Board of FRISQ has decided to accommodate this request.
 
Cambio will offer FRISQ a loan of an additional SEK 3 million to ensure the financing of FRISQ's operations during this extended period.
 
The Board of FRISQ Holding will publish more information when it is available.

For further information:

Mats Lindstrand, CEO FRISQ Holding AB
E-mail: investor@frisq.se

About FRISQ:

FRISQ is a healthtech company built on the conviction that the quality of the care you get should not be dependent on your ability to navigate a complex system and constantly evolving treatments. The software solution FRISQ Care enables the creation of personalized, digital care plans that facilitate collaboration and secure information sharing between care teams, doctors and patients through the same platform.

Since 2016, FRISQ has been listed on Nasdaq First North Stockholm under the symbol “FRISQ”. FNCA Sweden AB is FRISQ’s Certified Adviser and can be reached via the following contact information: +46 8 528 00 399, info@fnca.se

The publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail.

For more information, please visit: www.frisqholding.se

Attachments

FRISQ extends the exclusive period for Cambio to make a final offer regarding FRISQ Holding's operative business

© Modular Finance, source Nordic Press Releases